CORRESP Filing
Nextel Medical Corp.
Date: Sept. 4, 2025 · CIK: 0001492448 · Accession: 0001079973-25-001423
AI Filing Summary & Sentiment
File numbers found in text: 024-12629
Show Raw Text
CORRESP 1 filename1.htm Correspondence EXOUSIA PRO, INC. 7901 4th Street N #23494 St. Petersburg, Florida 33702 September 4, 2025 VIA EDGAR Uwem Bassey Office of Technology Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Exousia Pro, Inc. (the "Company") Offering Statement on Form 1-A (the "Offering Statement") File No. 024-12629 Dear Mr. Bassey: On behalf of the Company, I respectfully request that the qualification date of the Offering Statement be accelerated and that the Offering Statement be declared qualified Monday, September 8, 2025, at 3:00 p.m. EDT, or as soon thereafter as is reasonably practicable. In making this request, the Company represents that the Offering Statement will be approved in the State of Colorado, upon qualification by the Securities and Exchange Commission (the "Commission"), and acknowledges the following: - should the Commission or the Staff, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing; - the action of the Commission or the staff, acting pursuant to delegated authority, to declare the filing qualified does not relieve the Company from its full responsibility for the adequacy and accuracy of disclosure in the filing; and - the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities law of the United States. Very truly yours, /s/ Michael Sheikh Michael Sheikh Chief Executive Officer Exousia Pro, Inc.